Avalo Therapeutics, Inc. Common Stock

AVTXNASDAQ • USD
ThemeBiotech - Drug Development›Immunology & Autoimmune
6.75 USD
↘ 0.02 (0.30%)AT CLOSE (03:59 PM EDT)
6.68
↘ 0.07 (1.08%)
POST MARKET (AS OF 07:42 PM EDT)
Post Market
AS OF 07:42 PM EDT
6.68
↘ 0.07 (1.08%)
🔴Market: CLOSED

Shares of Avalo Therapeutics, Inc. Common Stock (AVTX) are trading at $6.75. Both sides of the analysis point lower: technicals flash "Strong Sell" and fundamentals confirm with a "Sell" reading. Notable factors include a robust Altman Z-Score, a weak Piotroski F-Score of 0/9, negative Return on Equity, a bearish Death Cross on the long-term moving averages and bearish long-term moving average alignment. Valuation metrics place AVTX at a fair price relative to peers.

Technical & fundamental data as of Oct 27, 2026.

Open?$6.91
High?$6.98
Low?$6.58
Prev. Close?$6.77
Volume?2.6M
Avg. Volume?2.2M
VWAP?$6.73
Rel. Volume?1.19x
Bid / Ask
Bid?$6.60 × 100
Ask?$7.00 × 500
Spread?$0.40
Midpoint?$6.80
Valuation & Ratios
Market Cap?362.0M
Shares Out?53.6M
Float?48.6M
Float %?90.6%
P/E Ratio?N/A
P/B Ratio?0.81
EPS?-$1.87
Dividend?0.00%
Ex-Dividend?N/A
News
Profile
Avalo Therapeutics Inc is a clinical stage biotechnology company fully dedicated to developing IL-1B-based treatments for immune-mediated inflammatory diseases. The company's asset is Abdakibart (AVTX-009) an anti-IL-1B monoclonal antibody ("mAb"), targeting inflammatory diseases. Avalos pipeline also includes quisovalimab (anti-LIGHT mAb) and AVTX-008 (BTLA agonist fusion protein), AVTX-006 and AVTX-913.
Themes
Biotech - Drug Development›Immunology & Autoimmune
Employees
33
Market Cap
363.1M
Industry
PHARMACEUTICAL PREPARATIONS
Website
www.avalotx.com
Listed
2015-11-13
Address
1500 LIBERTY RIDGE DRIVE
WAYNE, PA 19087
Phone: 410-522-8707
Technical OutlookStrong Sell
Strong SellNeutralStrong Buy
Long-Term (Tide)?▼ Bearish(-3/3)
Medium-Term (Wave)?▼ Bearish(-2/3)
Short-Term (Ripple)?▼ Bearish(-3/3)
MA Alignment?Bearish Alignment
Full Technical Analysis →
Fundamental OutlookSell
Strong SellNeutralStrong Buy
F-Score?
3
Z-Score?
92
Momentum?
50
Short Sent.?
19
Piotroski F-Score?0/9Weak
Altman Z-Score?4.05Safe
Confidence?48%Low
Full Fundamental Analysis →
Short InterestSqueeze Risk
Short % of Float?24.62%Squeeze Risk
Short Interest?12.0M
Days to Cover?13.0
Free Float48.6M
Avg Daily Volume919.7K
Settlement Date2026-10-15
Financial Health
Current Ratio?19.31Strong
Quick Ratio?19.31Strong
Cash Ratio?4.04Strong
Debt/Equity?0.00Low
ValuationFAIRLY VALUEDvs 1 peers + S&P 500
Score
67/100
P/E?
N/A▾
P/B?
Peers
100
S&P
97
0.81CHEAP▾
P/S?
Peers
100
S&P
3
6,135.63HIGH▾
P/FCF?
N/A▾
EV/EBITDA?
S&P
97
-3.0CHEAP▾
EV/Sales?
Peers
100
S&P
3
4,688.48HIGH▾
Returns & Efficiency
ROE?
S&P
7
-22.4%WEAK▾
ROA?
S&P
3
-20.4%WEAK▾
Cash Flow & Enterprise
FCF?$-68290000
Enterprise Value?$276.6M
Fundamentals ratios updated end of day
MarketsMoversWatchlist